- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0018951

Martin & Brown Bio-Sciences Private Limited
About Martin & Brown Bio-Sciences Private Limited
Data last updated:
Martin & Brown Bio-Sciences Private Limited is a private limited company based in Nalagarh, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 April 2023.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U21009HP2023PTC010046.
The company has an authorised share capital of ₹6.4 Cr and a paid-up capital of ₹5.53 Cr. It is led by directors Puneet Maini and Vineet Maini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.52 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 1.7%) and EBITDA of ₹4.66 Cr (EBITDA margin 5.3%).
As per MCA filings, the company has open charges of ₹18.04 Cr on record. Court records list 20 cases involving the company, including 12 filed by the company and 8 filed against it; 12 cases are pending.
Martin & Brown Bio-Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0018951).
Company details
Recognitions & Rankings of Martin & Brown Bio-Sciences
Contact details
Martin & Brown Bio-Sciences Private Limited's registered office is in Nalagarh, Himachal Pradesh.
- Registered AddressKhasra No 918/419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Martin & Brown Bio-Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Martin & Brown Bio-Sciences Private Limited, buy the company report.
Financials of Martin & Brown Bio-Sciences Private Limited
FY 2025 filings availableMartin & Brown Bio-Sciences Private Limited reported revenue of ₹88.52 Cr (up 75% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 75% in the latest year. EBITDA rose 29% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹4.66 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹1.51 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.3% | |
| Net Profit Margin | 1.7% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Martin & Brown Bio-Sciences Private Limited, buy the company report.
Board of directors of Martin & Brown Bio-Sciences Private Limited
Martin & Brown Bio-Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puneet Maini | Director | 28 Apr 2023 | 3 Years 6 Months | Current |
| Vineet Maini | Director | 28 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Martin & Brown Bio-Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medilux Laboratories Pvt Ltd | ₹89.42 Cr (FY 2018) | -2.0% | Indore, Madhya Pradesh, India | |||
| Evertogen Life Sciences Limited | ₹89.28 Cr (FY 2024) | 51.0% | Hyderabad, Telangana, India | |||
| U S Pharma (India) Private Limited | ₹89.26 Cr (FY 2025) | 421.0% | Mumbai, Maharashtra, India | |||
| Gnosis Pharmaceuticals Private Limited | ₹88.76 Cr (FY 2024) | 18.0% | New Delhi, Delhi, India | |||
| Martin & Brown Bio-Sciences Private Limitedthis company | ₹88.52 Cr (FY 2025) | ₹1.51 Cr | 1.7% | 75.0% | Nalagarh, Himachal Pradesh, India | |
| Ravian Life Science Private Limited | ₹88.41 Cr (FY 2025) | 2.0% | Haridwar, Uttarakhand, India | |||
| SRS Pharmaceuticals Private Limited | ₹88.26 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Appasamy Ocular Devices Private Limited | ₹87.93 Cr (FY 2022) | 60.0% | Chennai, Tamil Nadu, India | |||
| BDH Industries Limited | ₹87.41 Cr (FY 2024) | 16.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Martin & Brown Bio-Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2024 | 100888531 | State Bank of India | ₹18.04 Cr | Open |
To see the full charge records of Martin & Brown Bio-Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Martin & Brown Bio-Sciences Private Limited has 20 court cases on record: 12 filed by Martin & Brown Bio-Sciences, 8 filed against it. 12 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 1 | 6 |
| District courts | 9 | 7 | 6 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Execution petition | Filed against the company by Om Logistics Limited | Pending |
| Patna High Court | Court case (CWJC) | Filed by the company against The Managing Director, Bihar Medical Services and Infrastructure Corporation Ltd., and 3 others | Pending |
| Patna High Court | Court case (REQ. CASE) | Filed by the company against Bihar Medical Services and Infrastructure Corporation Ltd., | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed by the company against Om Logistics Limited | Pending |
| Patna High Court | Court case (CWJC) | Filed by the company against Bihar Medical Services and Infrastructure Corporation Ltd., and 1 other | Disposed |
To see the full case history of Martin & Brown Bio-Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Martin & Brown Bio-Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Martin & Brown Bio-Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Martin & Brown Bio-Sciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Puneet Maini was appointed as Director on 28 Apr 2023.
Frequently asked questions
Martin & Brown Bio-Sciences is an active private limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 April 2023 (3+ years old) and is registered under CIN U21009HP2023PTC010046.
Martin & Brown Bio-Sciences has 2 current directors:
- Puneet Maini - Director
- Vineet Maini - Director
The latest financial statements of Martin & Brown Bio-Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Martin & Brown Bio-Sciences is U21009HP2023PTC010046. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Martin & Brown Bio-Sciences has 20 court cases on record: 12 filed by the company and 8 filed against it. 12 are pending. Most are in the high courts.
Martin & Brown Bio-Sciences was incorporated on 28 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Martin & Brown Bio-Sciences by revenue are Medilux Laboratories Pvt Ltd, Evertogen Life Sciences Limited, U S Pharma (India) Private Limited, Gnosis Pharmaceuticals Private Limited, Ravian Life Science Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Puneet Maini was appointed as Director on 28 Apr 2023. Vineet Maini was appointed as Director on 28 Apr 2023.
Yes, Martin & Brown Bio-Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0018951).
The registered office of Martin & Brown Bio-Sciences is at Khasra No 918419 Malku Majra, Nalagarh, Himachal Pradesh, India – 173205.
Martin & Brown Bio-Sciences operates in the pharma industry, in the drug formulation and development segment.

